Source: WRAL TECHWIRE, 1/7/20

Startup Boragen just closed on $2 million in new financing. Now it has in hand a research-and-development deal for work in animal health. Boragen did not identify its new partner other than to describe the firm as “a global leading animal health company.” Financial terms were not disclosed either. “[T]he company will have an exclusive option to a license to develop and commercialize lead compounds in the Animal Health Field,” Boragen noted.

For more of this story, click here.